ARGENX SE

ARGX
Real-time Estimate Quote. Real-time Estimate  - 10/27 03:59:51 pm
217.6EUR +3.82%
Prev.209.6000
Open211.2000
High218.6000
Low208.0000
Volume93 853
Latest news
5d ago
5d ago
5d ago
10/16
Chart ARGENX SE
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance239239235
Spread/Res.-8,5%-8,5%-7,0%
Spread/Supp.6,2%19%45%
Support206183150
Financials
Sales 2020 60,2 M 70,9 M 70,9 M
Net income 2020 -477 M -562 M -562 M
Net cash 2020 1 358 M 1 599 M 1 599 M
P/E ratio 2020 -23,9x
Yield 2020 -
Capitalization 10 339 M 12 236 M 12 179 M
EV / Sales 2020 149x
EV / Sales 2021 79,8x
Nbr of Employees 186
Free-Float 99,8%
Company
argenx SE is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The group is focused on developing product candidates with the potential to be either first-in-class against novel...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-03-04 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 237,65 €
Last Close Price 218,40 €
Spread / Highest target 32,8%
Spread / Average Target 8,82%
Spread / Lowest Target -1,56%